Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

URBAN ARCH 4/5 Russia Cohort-Targeting HIV-comorbidities With Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected Russians

NCT02797587 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.

NCT NCT02797587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02797587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
URBAN ARCH 4/5 Russia Cohort-Targeting HIV-comorbidities With Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected Russians
Lead sponsor
Boston Medical Center
Phase
Phase 2/3
Overall status
Completed
Start date
July 19, 2017
Completion date
December 15, 2020
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use, hiv infection, smoking